Corticosteroids for elderly patients with breast cancer.
Ninety-one assessable elderly women (greater than 65 years) with advanced breast cancer were treated with prednisolone 15 mg (or cortisone 75 mg) daily after primary endocrine treatment (estrogens, androgens or tamoxifen). Thirteen (14%) achieved an objective regression, and 19 (21%) others showed no change for greater than or equal to six months. Hence, 32 patients (35%) had control of disease for about one year. Responses were mainly in soft tissue and skeletal lesions and were independent of response to prior endocrine treatment. Toxicity was low. Low-dose corticosteroid treatment is of value in controlling advanced breast cancer in elderly women.
D000368:Aged; D000728:Androgens / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D003348:Cortisone / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use
D000728:Androgens; D004967:Estrogens; D013629:Tamoxifen; D011239:Prednisolone; D003348:Cortisone